Retina Group

Sevilla, Spain

Retina Group

Sevilla, Spain
SEARCH FILTERS
Time filter
Source Type

News Article | April 25, 2017
Site: www.prweb.com

Retina Group of New York (RGONY) is pleased to announce support as an exhibitor for “SEE FOR YOURSELF 2017,” a Low Vision/Technology Resource Fair for people who are blind or visually impaired, at the Suffolk Cooperative Library System (SCLS) on Friday, May 5, 2017 any time between 9:00 am and 3:00 pm. Admission is free. It is recommended to leave at least 90 minutes to visit all the exhibitors. The "SEE FOR YOURSELF" Low Vision/Technology Fair will be held at The Suffolk Cooperative Library, 627 North Sunrise Service Road, (Exit 55), Bellport, New York 11713, (East of Route 101, Patchogue-Yaphank Road). Information is available by calling 631-286-1600 (voice) or TTY: 631-286-4546. Please contact them in advance if reasonable accommodation for a disability is required. Transportation cannot be provided. Vendors will provide “hands-on” demonstrations of assistive technology, while representatives from several non-profit organizations, county agencies and service providers will offer information that will enhance the lives of people living with vision loss including: Also, look for representatives from your public library to learn about the resources that they offer. James M. Maisel, MD, Chairman and Founder of Retina Group of New York, served on the American Academy of Ophthalmology Low Vision Committee and is a recognized expert in diagnosis and treatment of many of the leading causes of blindness including macular degeneration, diabetic retinopathy, and retinal degenerations. According to Dr. Maisel, “The Low Vision/Technology Fair is a unique opportunity for patients with low vision to obtain information about many low vision and non-visual aids and support services in one location. The Retina Group of New York will be providing educational information for patients with visual impairment regarding newer procedures, technologies and medications to diagnose, prevent or regain vision.” About Retina Group of New York The Retina Group of New York has provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macular pucker, macula hole, surgery complications, uveitis, Plaquenil toxicity, retinal degenerations and second opinions. For more information on The Retina Group of New York, visit http://www.rgony.com, or call 516-939-6100 or 631-273-1818 for appointments. About Outreach Services, Suffolk Cooperative Library System Founded in 1961, the Suffolk Cooperative Library System exists to help local public libraries provide the best in traditional and innovative public library service to all the people of Suffolk County at numerous branches throughout Suffolk County. The Suffolk Cooperative Library System is also the home of the Long Island Assistive Technology Center. This area of the library system is dedicated to assistive technology for individuals who cannot use traditional print materials. The “Center” offers free demonstrations of Adaptive hardware and software for people living with a visual or a learning disability. Demonstrations in the center are by appointment only.


News Article | April 25, 2017
Site: www.prweb.com

Retina Group of New York (RGONY) is pleased to be a sponsor, speak about “Diabetic Retinopathy Prevention, Detection and Treatment” and provide no-cost retinopathy screening at the Island of Flatbush...(PRWeb April 25, 2017)Read the full story at http://www.prweb.com/releases/Diabetes/retinopathy/prweb14270172.htm


News Article | July 18, 2017
Site: www.prweb.com

James M. Maisel, MD, Chairman of Retina Group of New York, chairs the Epidemiology and Prevention of Diabetes section at the 5th World Congress of Diabetes 2017, July 12-14, 2017 in Prague, Czech Republic. Dr. Maisel will lecture on the topic of “Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy.” James M. Maisel, MD, a retinal specialist and recipient of the Juvenile Diabetes Research Foundation Humanitarian of the Year Award 2017, works with patients to prevent and treat diabetic retinopathy and complications, through education and sight-saving pharmacologic treatment. “I am delighted to participate in the 5th World Congress of Diabetes as a section chair and presenter,” states Dr. Maisel. “We are beginning to understand the multifactorial complexity of ocular diabetic disease, but it remains one of the leading causes of blindness in the US in the 18-64 age group. Untangling the intricacy of cases that do not respond well to evidence based established treatment still requires extensive experience, analysis of multifactorial considerations and expertise in medical, laser and surgical treatment.” The abstract of Dr. Maisel’s presentation, “Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy,” is available at rgony.com and the presentation will be posted afterwards. Dr. Maisel, who is also Chairman and CEO of ZyDoc, a New York-based medical informatics company, will deliver a second presentation for the World Diabetes Congress entitled “Using Natural Language Processing (NLP) to Identify and Manage Patient Populations at Risk for Diabetes and Diabetic Complications.” That abstract is available at http://www.zydoc.com, with the presentation later posted. The 5th World Diabetes Congress is hosted by BIT Group Global Ltd in Prague, Czech Republic, at the Vienna House Diplomat Prague. More information is available online at http://www.bitcongress.com/wce2017. About Retina Group of New York (RGONY) The Retina Group of New York has provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting-edge diagnostic equipment, and integrated electronic records. The group holds staff privileges at eight area hospitals and teaching appointments at the Hofstra Northwell School of Medicine, North Shore University Hospital, and NuHealth Nassau University Medical Center. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macular pucker, macula hole, surgery complications, uveitis, Plaquenil toxicity and second opinions. For more information on The Retina Group of New York, visit http://www.rgony.com or call 516-939-6100.


News Article | July 28, 2017
Site: www.prweb.com

James M. Maisel, MD, Chairman and CEO of ZyDoc, a New York-based medical informatics company, was honored to have chaired the Epidemiology and Prevention of Diabetes section at the 5th World Congress of Diabetes 2017, July 12-14, 2017 in Prague, Czech Republic. Maisel, who is also chairman of Retina Group of New York and recipient of the Juvenile Diabetes Research Foundation Humanitarian of the Year Award 2017, lectured on the topic of “Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy.” A second presentation delivered by Maisel at the conference explored “Using Natural Language Processing (NLP) to Identify and Manage Patient Populations at Risk for Diabetes and Diabetic Complications." As a retinal specialist, Maisel works with patients to prevent and treat diabetic retinopathy and complications, through education and sight-saving pharmacologic treatment. “I am delighted to have participated in the 5th World Congress of Diabetes as a section chair and presenter,” states Dr. Maisel. “We are beginning to understand the multifactorial complexity of ocular diabetic disease, but it remains one of the leading causes of blindness in the US in the 18-64 age group. Untangling the intricacy of cases that do not respond well to evidence based established treatment still requires extensive experience, analysis of multifactorial considerations and expertise in medical, laser and surgical treatment.” The abstract of Dr. Maisel’s presentation, “Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy,” is available at rgony.com along with the presentation. A second presentation by Dr. Maisel for the 5th World Congress of Diabetes focused on “Using Natural Language Processing (NLP) to Identify and Manage Patient Populations at Risk for Diabetes and Diabetic Complications.” ZyDoc's cloud based, NLP-driven medical intelligence platform, MediSapien, enables movement of unstructured text to EHRs, allowing doctors to dictate encounters and auto-insert section-level information. A specialized use of MediSapien is in the development of Pharma real-world evidence (RWE) applications. The abstract and presentation are available at http://www.zydoc.com. The 5th World Congress of Diabetes was hosted by BIT Group Global Ltd in Prague, Czech Republic, at the Vienna House Diplomat Prague. More information is available online at http://www.bitcongress.com/wce2017. About ZyDoc and MediSapien In 2013, ZyDoc's MediSapien software was ranked as one of the top five applications in The Data Design Diabetes Sanofi US Innovation Challenge. MediSapien for Pharma enables the development of sophisticated, highly targeted RWE applications. ZyDoc’s mission since the company's inception in 1993 has been to increase the efficiency of physicians through the use of software technology and services to improve patient care and outcomes, lower malpractice risk, and maximize reimbursement. Based in Islandia, New York, ZyDoc has developed award-winning, HIPAA-secure, cloud-based e-transcription infrastructure and medical informatics technologies, serving medical practices, hospitals, public health agencies, and other entities in the medico-legal, academic, and pharmacology sectors. Augmenting ZyDoc’s transcription business, MediSapien is a web-based knowledge management platform that uses disruptive natural language processing and AI technologies to convert unstructured text to fully coded structured data for EHRs, PACS, RIS, analytics, and reporting. For clinician end-users, MediSapien can be utilized in conjunction with EHR installations and can facilitate analytic applications for individual or population disease management for ACOs, hospitals or large groups. ZyDoc is a VMWare Professional Solution Provider Partner. For more information about ZyDoc and MediSapien, please visit zydoc.com. About Retina Group of New York (RGONY) The Retina Group of New York has provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting-edge diagnostic equipment, and integrated electronic records. The group holds staff privileges at eight area hospitals and teaching appointments at the Hofstra Northwell School of Medicine, North Shore University Hospital, and NuHealth Nassau University Medical Center. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macular pucker, macula hole, surgery complications, uveitis, Plaquenil toxicity and second opinions. For more information on The Retina Group of New York, visit http://www.rgony.com or call 516-939-6100.


News Article | December 5, 2016
Site: www.prweb.com

Sabah Shah MD, MBA has joined the Retina Group of New York (RGONY) specializing in uveitis and vitreoretinal surgery. The Retina Group of New York was founded by James M. Maisel, MD and has been providing tertiary medical and surgical retinal care on Long Island for over 30 years. Dr. Shah has always followed a legacy of surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. Shah emulated the role of a physician as a medical healer. At the age of 17, she was only one of 18 high school students in the entire country accepted directly into medical school from high school. She was granted direct admission into the 8-year Leadership in Medicine program at Union University and Albany Medical College. She excelled academically during her studies, attaining a dual Bachelor’s degree in Biology and Spanish, an MBA in healthcare administration, and lastly her medical degree from Albany Medical College. After graduating at the top of her class from Albany Medical College, Dr. Shah completed her internship at New York Presbyterian-Queens of Weill Cornell Medical Center. She then completed a prestigious three-year ophthalmology residency at New York University and Manhattan Eye, Ear & Throat Hospital, training under world-renowned retina specialists. Upon completing her residency training, Dr. Shah returned to upstate New York to complete a two-year combined fellowship in vitreoretinal surgery and uveitis. Dr. Shah was appointed as Assistant Professor of Ophthalmology at Albany Medical College and was awarded the Resident Teaching Award for her excellence in instructing surgical and medical techniques to residents. During her training, Dr. Shah has published numerous papers on anti-VEGF medications including Avastin, Lucentis and Eylea, and procedures that are currently used by retina specialists such as retinal detachment repair and macular pucker surgery. She has participated in ongoing clinical trials involving pathology for macular degeneration and uveitis. Furthermore, Dr. Shah has presented her research, received research scholarships and awards, and has given lectures at the national level to hundreds of physicians across the country. Dr. Maisel states, “It is a privilege to have Dr. Shah join RGONY as the only ophthalmologist on Long Island to be fellowship trained in both retina and uveitis. Dr. Shah has extensive experience in some of the most sophisticated and groundbreaking medical and surgical techniques and we look forward to having her bring that expertise to RGONY and our patients. She has performed thousands of eye injections, retina lasers, and surgery for retinal detachment, macular puckers, and vitrectomies. Her comprehensive training, coupled with her amiable personality makes her a valuable addition to our specialized tertiary retina and uveitis practice.” Dr. Shah adds, “It is an honor to be a part of the medical and surgical community specializing in the management of retina and uveitis patients in Long Island. Having grown up in Long Island, I am excited to come back to serve my community. I enjoy meeting new patients and my passion in life is my career which enables me to restore vision and independence.” About the Retina Group of New York The Retina Group of New York has provided tertiary retinal and uveitis care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting edge diagnostic imaging, and integrated electronic records. The group holds staff privileges at seven area hospitals and teaching appointments at the Hofstra North Shore-LIJ School of Medicine, North Shore University Hospital, and Nassau University Medical Center. The practice is limited to medical and surgical retinal and uveitis problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macula pucker, macula hole, cataract surgery complications, uveitis, retinal degenerations, Plaquenil toxicity and second opinions. The group, led by CEO and founder James M. Maisel, MD, consists of Board Certified Ophthalmologists who have additional Fellowship Training from top institutions including New York Presbyterian-Cornell Medical Center, University of Pittsburgh and Albany Medical Center. They are complemented by specialized ophthalmic certified RNs, Health Information Management Specialists and Ophthalmic Technicians.The Retina Group of New York utilizes state-of-the-art diagnostic equipment and offers in-office laser treatment for diabetic retinopathy and treatment for macular degeneration and diabetic macular edema with intravitreal medications including Eylea®, Lucentis®, Ozurdex® and Iluvien®. Keeping abreast of the latest treatments, members of the group serve on the medical advisory boards of Regeneron, Allergan, Genetech and Alimera, and lecture across the U.S. to other retina specialists about macular degeneration and diabetic retinopathy. More information is available online at http://www.rgony.com.


Lukovic D.,Retina Group | Moreno-Manzano V.,Research Center Principe Felipe | Klabusay M.,St Annes University Hospital Brno | Stojkovic M.,Spebo Medical | And 3 more authors.
Frontiers in Genetics | Year: 2014

Several studies have demonstrated the important role of non-coding RNAs as regulators of posttranscriptional processes, including stem cells self-renewal and neural differentiation. Human embryonic stem cells (hESCs) and induced pluripotent stem cells (ihPSCs) show enormous potential in regenerative medicine due to their capacity to differentiate to virtually any type of cells of human body. Deciphering the role of non-coding RNAs in pluripotency, self-renewal and neural differentiation will reveal new molecular mechanisms involved in induction and maintenances of pluripotent state as well as triggering these cells toward clinically relevant cells for transplantation. In this brief review we will summarize recently published studies which reveal the role of non-coding RNAs in pluripotency and neural differentiation of hESCs and ihPSC. © 014 Lukovic, Moreno-Manzano, Klabusay, Stojkovic, Bhattacharya and Erceg.


News Article | February 15, 2017
Site: www.prweb.com

The American Diabetes Association of Greater New York and the Retina Group of New York proudly announce the 2017 EXPO being held on March 11, 2017, in the North Wing of the Jacob Javits Convention Center from 10am to 4pm. The Retina Group of New York, a leading Long Island group of vitreoretinal physicians, will be a presenting sponsor. James M. Maisel, MD, Founder and CEO of the Retina Group of New York will be speaking on “Advances in Diabetic Retinopathy Prevention, Diagnosis and Treatment.” This free community event will feature complimentary health screenings, healthy cooking demonstrations from celebrity chefs, exercise tips from nutrition and fitness experts, access to healthcare providers, multilingual presentations regarding diabetes prevention, multicultural community areas, a living-with-type 1 diabetes area, and a diabetes-goes-digital area. “The Retina Group of New York is committed to raising awareness about the need for regular screening for all diabetic patients for diabetic retinopathy, and in the prevention, diagnosis and treatment of diabetic retinopathy. In addition to faster and more accurate diagnosis of diabetic retinopathy, we are not only able to prevent blindness in almost all patients with laser and vitreous microsurgery, we can often improve vision with newer FDA approved medications,” said Dr. Maisel. “We are proud to serve as a presenting sponsor of the American Diabetes Association EXPO and to help reduce the prevalence of this preventable disease.” More than 10,000 attendees are expected from the Greater New York region. The EXPO aims to attract families affected by diabetes as well as those interested in learning how to live healthier, active lifestyles and changing the future of diabetes. “Every 11 seconds someone is diagnosed with diabetes,” said James Sheridan, Regional Vice President at the American Diabetes Association. “The fact is, nearly 30 million adults and children in the United States have diabetes—nearly 10 percent of the population. That percentage is even higher in New York City, reaching 14% in the African American and Latino population. And shockingly, many do not even know that they have the disease. That is why screening is so important.” Free, early registration is available at http://www.diabetes.org/exponyc About the American Diabetes Association The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, the Association’s mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. About The Retina Group of New York The Retina Group of New York has provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting-edge diagnostic equipment, and integrated electronic records. The group holds staff privileges at eight area hospitals and teaching appointments at the Hofstra Northwell School of Medicine, North Shore University Hospital, and NuHealth Nassau University Medical Center. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macular pucker, macula hole, surgery complications, uveitis, Plaquenil toxicity and second opinions. For more information on The Retina Group of New York, visit http://www.rgony.com, or call 516-939-6100 or 631-273-1818 for appointments.

Loading Retina Group collaborators
Loading Retina Group collaborators